These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20387069)

  • 1. α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume.
    Yokoyama O; Aoki Y; Tsujimura A; Takao T; Namiki M; Okuyama A
    World J Urol; 2011 Apr; 29(2):233-8. PubMed ID: 20387069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].
    Iwaki H; Narita M; Soga H; Sakano Y; Konishi T; Okada Y
    Hinyokika Kiyo; 2010 Apr; 56(4):209-13. PubMed ID: 20448444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
    Takahashi S; Tajima A; Matsushima H; Kawamura T; Tominaga T; Kitamura T
    Int J Urol; 2006 Jan; 13(1):15-20. PubMed ID: 16448426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study).
    Matsukawa Y; Funahashi Y; Takai S; Majima T; Ogawa T; Narita H; Kato M; Gotoh M
    J Urol; 2017 Feb; 197(2):452-458. PubMed ID: 27615436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naftopidil on nocturia after failure of tamsulosin.
    Oh-oka H
    Urology; 2008 Nov; 72(5):1051-5. PubMed ID: 18817955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia--analysis of frequency volume charts].
    Masuda M; Nakayama K; Hiromoto Y; Hirokawa M; Satomi Y; Shiramizu M; Furuhata A; Ikeda A; Kawasaki C
    Hinyokika Kiyo; 2004 May; 50(5):309-14. PubMed ID: 15237482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: comparison of morning and evening dosing.
    Tanaka T; Kuratsukuri K; Yoshimura R; Adachi T; Yamaguchi T; Ohmachi T; Yamamoto S; Nakamura T; Tamada S; Nakatani T
    Int J Urol; 2015 Mar; 22(3):317-21. PubMed ID: 25421868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study.
    Yokoyama O; Tsujimura A; Akino H; Segawa N; Tamada S; Oguchi N; Kitagawa Y; Tsuji H; Watanabe A; Inamoto T; Shimizu N; Fujiuchi Y; Katsuoka Y; Azuma H; Matsuda T; Namiki M; Uemura H; Okuyama A; Nonomura N; Fuse H; Nakatani T
    World J Urol; 2015 May; 33(5):659-67. PubMed ID: 25224929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The α1 adrenoceptor antagonist tamsulosin for the treatment of voiding symptoms improves nocturia and sleep quality in women.
    Kim SO; Choi HS; Kwon D
    Urol J; 2014 Jul; 11(3):1636-41. PubMed ID: 25015610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].
    Nakatsu H; Naoi M; Sekiyama K; Hamano S; Suzuki N; Tanaka M; Murakami S
    Hinyokika Kiyo; 2007 Jan; 53(1):13-8. PubMed ID: 17310763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
    Tsumura H; Satoh T; Ishiyama H; Tabata K; Kotani S; Minamida S; Kimura M; Fujita T; Matsumoto K; Kitano M; Hayakawa K; Baba S
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e385-92. PubMed ID: 21664068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia].
    Hayashi T; Sakai Y; Saito K; Arai G; Hyochi N; Suzuki M; Masuda H; Kawakami S; Okuno T; Kobayashi T; Kageyama Y; Kihara K
    Hinyokika Kiyo; 2002 Jan; 48(1):7-11. PubMed ID: 11868386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
    Saito M; Shimizu S; Ohmasa F; Oikawa R; Tsounapi P; Dimitriadis F; Kinoshita Y; Satoh K
    Neurourol Urodyn; 2013 Apr; 32(4):393-8. PubMed ID: 22907830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
    Kamimura N; Hatakeyama S; Kudo S; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Kawaguchi T; Takahashi S; Ohyama C
    Hinyokika Kiyo; 2011 Feb; 57(2):71-6. PubMed ID: 21412038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of naftopidil on lower urinary tract symptoms after radical prostatectomy.
    Ishizaka K; Machida T; Tanaka M; Kawamura N; Nakamura K; Kihara K
    Int J Urol; 2009 Mar; 16(3):299-302. PubMed ID: 19207610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association with relative nocturnal polyuria using BNP (brain natriuretic peptide) in eldely patients with nocturia].
    Sone A; Kondo N; Kobayashi T; Koide T; Furukaw Y; Kinugawa K; Morioka M; Shuto K; Nagai A
    Nihon Hinyokika Gakkai Zasshi; 2007 Mar; 98(3):558-64. PubMed ID: 17419366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of nocturia with 24-h urine volume, nocturnal urine volume, nocturnal bladder capacity and length of sleep duration: concept for effective treatment modality.
    Udo Y; Nakao M; Honjo H; Ukimura O; Kawauchi A; Kitakoji H; Miki T
    BJU Int; 2011 Mar; 107(5):791-798. PubMed ID: 20804481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
    Xue Z; Lin Y; Jiang Y; Wei N; Bi J
    BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].
    Sugino Y; Fukuzawa S; Takeuchi H; Taki Y; Hashimura T; Soeda T; Araki I
    Hinyokika Kiyo; 2003 Aug; 49(8):445-9. PubMed ID: 14518379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.